BR101801

· Boryung Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BR101801, covering 2025-09-10 to 2025-09-10. Get the full timeline:

Most recent: Clinical Trial Update: BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) [Phase 1]